We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Mindfulness and Acceptance Group Therapy for Substance Use

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified December 2012 by The University of Tennessee, Knoxville.
Recruitment status was:  Recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT01751542
First Posted: December 18, 2012
Last Update Posted: December 18, 2012
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
The University of Tennessee, Knoxville
  Purpose
Randomized clinical trial comparing standard residential substance abuse treatment to standard residential treatment plus Mindfulness and Acceptance Group Therapy for substance use.

Condition Intervention Phase
Substance Use Disorder Behavioral: Mindfulness + Residential Treatment Behavioral: Residential treatment alone Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Mindfulness and Acceptance Group Therapy for Substance Use

Further study details as provided by The University of Tennessee, Knoxville:

Primary Outcome Measures:
  • Substance use after discharge from treatment [ Time Frame: 6 months ]

Estimated Enrollment: 150
Study Start Date: August 2012
Estimated Study Completion Date: December 2013
Estimated Primary Completion Date: December 2013 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Mindfulness + residential treatment
Mindfulness and Acceptance Group Therapy + residential treatment
Behavioral: Mindfulness + Residential Treatment
Active Comparator: Residential Treatment
Residential treatment alone
Behavioral: Residential treatment alone

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • participating in inpatient substance use treatment at treatment facility

Exclusion Criteria:

  • psychosis and mental impairment
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01751542


Locations
United States, Tennessee
University of Tenneessee & Cornerstone of Recovery Recruiting
Knoxville, Tennessee, United States, 37996
Contact: Gregory Stuart, PhD    865-974-3358      
Principal Investigator: Gregory L Stuart, PhD         
Principal Investigator: Ryan Shorey, MA         
Sponsors and Collaborators
The University of Tennessee, Knoxville
  More Information

Responsible Party: The University of Tennessee, Knoxville
ClinicalTrials.gov Identifier: NCT01751542     History of Changes
Other Study ID Numbers: 8888-B
First Submitted: December 13, 2012
First Posted: December 18, 2012
Last Update Posted: December 18, 2012
Last Verified: December 2012

Additional relevant MeSH terms:
Substance-Related Disorders
Chemically-Induced Disorders
Mental Disorders